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1135-87 Role of DNA-Binding Proteins Interacting With a- 
Myosin Heavy Chain Gene Repressor Element in 
Cardiac Hypertrophy 
Madhu Gupta, Mahesh P. Gupta, The Heart Institute for Children, Hope Children’s 
Hospital, Oak Lawn, IL, The University of Chicago, Chicago. IL 
Background: Loss of myocardial u-myosin heavy chain (a-MHC) content is associated 
with reduced contractile function during heart failure. We have previously identified a 
highly conserved purine-rich repressor element (PNR) participating in the reduced 
expression of this gene. This study describes isolation and characterization of PNR inter- 
acting proteins. 
Methods: Expression screening was performed on 14-day mouse embryonic heart 
cDNA library using PNR element as probe. Gel shift assay analyzed the DNA-protein 
interaction. Protein levels were measured by western analysis. Effect of cloned CDNA on 
endogenous levels of a-MHC transcripts utilrzed primary cultures of cardiac myocytes 
derived from neonatal rat hearts and adenovirus vectors expressing full-length cloned 
proteins. 
Results: After screening two million plaques, three proteins, Pets, Pur-a and Pur-6were 
isolated. Gel shift assay defined the sequence specific binding of these proteins to PNR 
element. Pets, a small (-20kda) protern of the Ets family, binds to double-stranded PNR 
element; Pur-a and Pur-6 bind only to the sense-strand of PNR element. In vitro synthe- 
sized Pets protein inhibited binding of Pur-a and Pur-6 proteins to PNR element, sug- 
gesting competition between ets and pur family of proteins in this binding. By western- 
blot analysis, high expression levels of Pur-a and PurQ, but not of Pets, were observed 
in rabbit hearts (n=5) subjected to pressure overload, as well as in human failing hearts 
(n=7). Adenoviral vectors expressing full-length Pur-a or Pur+ proterns viere infected 
into primary cultures of rat cardiac myocytes to study the effects of these proteins on 
endogenous expression of a-MHC gene. Over expressron of Pur-8 had marked negative 
regulatory effect (80%) on the expression of endogenous a-MHC transcripts; however, 
Pur-a had mild repressive effect (50%). When both Pur-8 and Pur-a were expressed in 
combination, a synergistic negative regulatory effect on a-MHC gene expression was 
observed. 
Conclusion: The single strand DNA-binding proteins, Pur-a and Purp, contribute to the 
reduced expression of a-MHC transcripts seen in heart failure. 
1135-88 Treatment With Eplerenone, an Aldosterone Antagonist 
Improved Ventricular Remodeling and Function Post 
Myocardial Infarction 
Jennv La Amy Rudolph, Gordon Moe, Ricardo Rocha, Fayez Dawood, Wen-Hu Wen, 
Jean Rouleau, Peter Liu, Heart & Stroke/Richard Lewar Centre of Excellence, University 
of Toronto, Toronto, ON, Canada, Toronto General & St. Michael’s Hospitals, Toronto, 
ON, Canada 
Background: Post myocardial infarction (MI), aldosterone can directly cause myocyte 
hypertrophy, fibroblast proliferation and inflammatory response, leading to maladaptive 
remodeling. Hypothesis: Aldosterone antagonists, such as Eplerenone, can favorably 
modulate LV remodeling post MI. Methods: MI model was created in Sprague Dawley 
rats (N=33) following LAD ligation. Animals were randomized to sham vehicle [SV] 
(N=lO). sham Eplerenone [SE] (N=lO), Ml Vehicle [MV] (N=6), and Ml Eplerenone [ME] 
(N=7) with Eplerenone administered in the diet (100 mg/kg/day) At day 35 post MI, ani- 
mals were evaluated for in viva LV area at end-diastole (LVAED) and LV Fractional 
Shortening (% FS) using echocardiography. In vitro ventricular function was assessed by 
Langendorfl to determine LV systolic pressured (SysP, mmHg), +dP/dt (mmHg/sec). LV 
diastolic circumference (Dia circ, cm), LV cavity area (Cav Ar, ems). and Pressure-Vol- 
ume (P-V, mmHg/mL) slope. Collagen was assessed with picosirius red stain. Results: 
See table. (data expressed as mean* SE; ‘pcO.05 vs. MV). Collagen was increased in 
the central scar area, but diminished in the normal zone in the ME group vs. MV. Con- 
clusion: Eplerenone significantly ameliorated LV function and remodeling post-MI by 
improving contractile function and decreasing LV area. Taken together these results indi- 
cate that aldosterone may be an important contnbutor to post Ml remodeling, and indi- 
cates a potential therapeutic role for aldosterone antagonist post Ml. 
Ventricular Function and Remodeling in All Groups 
sv SE MI Vehicle MI Eplerenone 
SysP 97.64 * 6.36 97 * 6.749 60.83 f 8.01 84.29+ 5.35* 
+dP/dt 6873 * 506 6760 r 679 4133 * 653 5571 * 292’ 
Dia circ 1.78iO.14 1.85a0.19 2.50 f 0.26 2.15 + 0.3’ 
Cav Ar 0.22 * 0.03 0.24 t 0.05 0.40 * 0.1 0.29 * 0.1 
P-V 0.49 * 0.07 0.52 t 0.07 0.70 * 0.07 0.57 * 0.07’ 
LVAED 0.46+0. 15 0.46 io.09 0.72 * 0.19 0.59 * 0.17 
%FS 42.46+11.5 47.38 + 6.35 26.36 f 10.9 28.28 * 12.4 
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1136-70 Patient Knowledge of Congestive Heart Failure: Insights 
From the REACT Study 
Evan E. Lockwood, Miriam Fradette, Marcel0 C. Shibata, Marilou Hervas-Malo, Ross T. 
Tsuyuki. University of Alberta, Edmonton, AB, Canada 
Background: REACT was a B-month randomized trial of patient education and support 
(ES) vs. usual care (UC) in patients admitted with congestive heart failure (CHF). It dem- 
onstrated a reduction in clinical events and costs favoring the ES group. Our goal was to 
compare knowledge of CHF and self-care activities relating to CHF between the ES and 
UC groups at about 1 year after completion of the REACT educational program. Meth- 
ods: Patients who completed REACT were questioned via telephone interview, using 
open-ended and prompted questions about heart failure, as well as CHF-specific self- 
care activities (salt and fluid restriction, daily weight measurement) and general self-care 
activities (exercise and daily rest). 
Results: A total of 1661234 patients were able to be contacted an average of 13 + 2 
months after the completion of REACT. Average age was 70 _+I2 years and duration of 
CHF for all patients was >l year. There were no differences between the ES and UC 
groups with regards to symptom recognition, rncluding dyspnea (62 vs. 62%) edema (25 
vs. 18%) or fatigue (33 vs. 23%). respectively. Open-ended questioning of self-care 
activities showed poor awareness in both groups, although the ES group had a better 
understanding of the importance of daily weights (13 vs. 1%). exercise (36 vs. 19%) and 
medication compliance (28 vs. 13%) (all p<O.O5). Upon prompted questioning, the ES 
group were more aware of the CHF-specific self-care activities vs. UC in terms of salt 
restriction (80 vs. 59%) fluid restriction (57 vs. 32%) and daily weight measurement (80 
vs. 44%) (all pc0.05). 
Conclusion: Overall, disease knowledge and self-care in this high-risk group of patients 
with CHF is poor. Patients randomized to the ES group demonstrated somewhat better 
knowledge of CHF self-care activities after 1 year. The need for ongomg patient educa- 
tion IS clear, however, the best strategy to provide this education remains unknown. 
1136-71 Low Intensity Is Better Than High Intensity Exercise 
Training in Chronic Heart Failure Patients Concerning 
Pulmonary Ventilation, Brain Natriuretic Peptide, and 
Quality of Life Evaluation: A Prospective Randomized 
Study 
Almir S. Ferraz, Edimar A. Bocchi. Guilherme V. Guimaraes, Romeu S. Meneghelo, 
tracema I. Umeda. Jose Eduardo M. Sousa, Institute Dante Pazzanese of Cardiology, 
S&o Paulo, Brazil, Heart Institute (InCor) University of SBo Paulo Medical School, SBo 
Paula, Brazil 
Background: Exercise training improves functional capacity in chronic heart failure 
(CHF). However, there are concerns regarding what exercise training intensity IS better 
for CHF patients (pts). Methods: 31 men, 54 * 2 yrs (mean * se), wrth nonischemic 
dilated cardiomyopathy, functional class 11-111, LVEF 28 * 1%. peak oxygen consumption 
(V02) = 17,4 + 0,6 mkkglmin were randomized into 3 groups: low intensity exercise train- 
rng (LO) - 9 pts, high intensity exercise training (HI) -11 pts, and control (CO) 10 pts, 
under optimal medical treatment. At baseline and at 6 months, all pts underwent maximal 
treadmill cardiopulmonary exercise testing, six minutes walking test, rest and peak type 
B natriuretic peptide (BNP), rest echocardiography (echo), skeletal muscle biopsy and 
quality of life score (QLS). Low intensity training was prescribed using the heart rate cor- 
responding to that immediately below the anaerobic threshold (67 * 3% of peak V02) 
and HI using the HR immediately below the respiratory compensation point (88 f 2% of 
peak V02). Results: Significant diferences from baseline are in the table (’ = p<O,O5, ** = 
p<O,Ol). Oxidative enzymes increased similarly in HI and LO but not in CO. Cardiac func- 
tion or dimensions by echo did not change in any group. Conclusions: HI and LO 
enhanced maximal and submaximal exercise capacity and oxidative enzymes. Only LO 
improved respiratory efficiency and QLS; and reduced rest and peak exercise BNP lev- 
els. LO program is efficacious and would be stimulated in CHF. 
